Pricing Log in Create free account

Monte Rosa Therapeutics, Inc. (GLUE) vs Inventiva S.A. Sponsored ADR (IVA)

Monte Rosa Therapeutics, Inc. and Inventiva S.A. Sponsored ADR are both Biotechnology companies. Monte Rosa Therapeutics, Inc. and Inventiva S.A. Sponsored ADR are of similar size ($874.5M and $867.9M). Inventiva S.A. Sponsored ADR grew revenue faster over the last twelve months: 547.9% against −61.3%. Monte Rosa Therapeutics, Inc. has the higher net margin (−186.2% vs −750.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Inventiva S.A. Sponsored ADR leads on 9 and Monte Rosa Therapeutics, Inc. on 7.

Valuation

Metric GLUE IVA Biotechnology median
P/E n/m n/m 10.60
P/S 15.18 7.43 9.40
P/B 2.15 2.13 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 6.97 1.54 9.02
Earnings yield (13.35%) (94.51%) (32.88%)
Free cash flow yield (16.33%) (94.32%) (23.13%)

Profitability

Metric GLUE IVA Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (214.46%) 0.00% 0.00%
Net margin (186.24%) (750.28%) 0.00%
Free cash flow margin (247.98%) 0.00% 0.00%
Return on equity (35.30%) 0.00% (51.96%)
Return on assets (22.63%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GLUE IVA Biotechnology median
Revenue growth (TTM) (61.26%) 547.89% 6.76%
EPS growth (last fiscal year) 53.06% 35.44% 29.88%
Revenue growth, 5-year CAGR — 8.33% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GLUE IVA Biotechnology median
Debt to equity 0.00 1.13 0.00
Current ratio 10.32 3.81 4.97
Net debt to EBITDA 8.22 0.29 1.01

Dividend

Metric GLUE IVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GLUE IVA Biotechnology median
Market cap 874.46m 867.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack